Literature DB >> 7139211

Impairment of the blood-brain barrier as an aetiological factor in paranoid psychosis.

R Axelsson, E Martensson, C Alling.   

Abstract

Possible psychiatric implications of impairment of the blood-brain barrier were studied in 25 patients with paranoid psychosis. Determination of the ratio between the albumin concentrations in cerebrospinal fluid and serum showed increased, indicating impairment of the blood-brain barrier, in seven patients and normal values in 18. The two groups were compared for clinical, pharmacokinetic, neurophysiological and anamnestic variables. The highly significant finding that onset of psychosis had occurred, on average, 20 years earlier in the patients with impairment of the blood-brain barrier than in those without suggests that such impairment might influence the development of psychosis in predisposed individuals.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7139211     DOI: 10.1192/bjp.141.3.273

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  15 in total

Review 1.  Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand?

Authors:  Nenad Vasic; Bernhard J Connemann; Robert C Wolf; Hayrettin Tumani; Johannes Brettschneider
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-12-16       Impact factor: 5.270

Review 2.  The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders.

Authors:  Emily G Severance; Dag Tveiten; Lief H Lindström; Robert H Yolken; Karl L Reichelt
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

3.  Impaired copper transport in schizophrenia results in a copper-deficient brain state: A new side to the dysbindin story.

Authors:  Kirsten E Schoonover; Stacy L Queern; Suzanne E Lapi; Rosalinda C Roberts
Journal:  World J Biol Psychiatry       Date:  2018-12-20       Impact factor: 4.132

4.  Blood-cerebrospinal fluid barrier in schizophrenic patients.

Authors:  K Bauer; J Kornhuber
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987

5.  Genes involved in pruning and inflammation are enriched in a large mega-sample of patients affected by Schizophrenia and Bipolar Disorder and controls.

Authors:  Marco Calabrò; Calabrò Marco; Antonio Drago; Drago Antonio; Antonina Sidoti; Sidoti Antonina; Alessandro Serretti; Serretti Alessandro; Concetta Crisafulli; Crisafulli Concetta
Journal:  Psychiatry Res       Date:  2015-06-26       Impact factor: 3.222

Review 6.  Viruses, schizophrenia, and bipolar disorder.

Authors:  R H Yolken; E F Torrey
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

7.  Antibodies to brain tissue in sera of schizophrenic patients--preliminary findings.

Authors:  A E Henneberg; S Ruffert; H J Henneberg; H H Kornhuber
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

8.  Blood-CSF barrier permeability and central nervous system immunoglobulin G in schizophrenia.

Authors:  D G Kirch; R C Alexander; R L Suddath; N M Papadopoulos; C A Kaufmann; D G Daniel; R J Wyatt
Journal:  J Neural Transm Gen Sect       Date:  1992

9.  Monoamine oxidase in young and adult rat brain capillaries.

Authors:  P H Yu
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

10.  Interactions between knockout of schizophrenia risk factor Dysbindin-1 and copper metabolism in mice.

Authors:  Kirsten E Schoonover; Laura J McMeekin; Charlene B Farmer; Neelu E Varghese; Stacy L Queern; Suzanne E Lapi; Rita M Cowell; Rosalinda C Roberts
Journal:  Brain Res Bull       Date:  2020-08-12       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.